Abnormalities in Tooth Formation after Early Bisphosphonate Treatment in Children with Osteogenesis Imperfecta.


Journal

Calcified tissue international
ISSN: 1432-0827
Titre abrégé: Calcif Tissue Int
Pays: United States
ID NLM: 7905481

Informations de publication

Date de publication:
08 2021
Historique:
received: 19 01 2021
accepted: 03 03 2021
pubmed: 21 3 2021
medline: 16 10 2021
entrez: 20 3 2021
Statut: ppublish

Résumé

Treatment with intravenous bisphosphonate (BP) in children and adolescents with osteogenesis imperfecta (OI) started in Sweden in 1991. No human studies on the role of BP therapy in development of disturbances in tooth mineralization or tooth morphology have been published. The study cohort comprised 219 individuals who were divided into four groups: group 1, BP treatment onset before 2 years of age (n = 22); group 2, BP treatment onset between 2 and 6 years of age (n = 20); group 3, BP treatment onset between 6 and 10 years of age (n = 13); and a control group of patients with OI who had not received BP therapy (n = 164). The chi-square test was used in between-group comparisons of the prevalence of tooth agenesis. The prevalence of tooth agenesis was significantly higher in children who began BP treatment before the age of 2 years (group 1; 59%,) compared to the controls (10%; p < 0.001) and to children who had begun BP therapy between ages 2 and 6 years (group 2; 10%; p = 0.009) or between ages 6 and 10 years (group 3; 8%; p = 0.003). Different types of disturbances in the enamel formation were seen in 52 premolars, where 51 were seen in those who began BP treatment before the age of 2 years. To conclude, starting BP treatment before the age of 2 years increases the risk of abnormalities in tooth formation manifesting as morphological aberrations, tooth agenesis, and enamel defects.

Identifiants

pubmed: 33743023
doi: 10.1007/s00223-021-00835-2
pii: 10.1007/s00223-021-00835-2
pmc: PMC8273054
doi:

Substances chimiques

Diphosphonates 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

121-131

Subventions

Organisme : Stiftelsen Olle Engkvist Byggmästare
ID : 191-449
Organisme : Stiftelsen Sunnerdahls Handikappfond
ID : 35/18
Organisme : Stiftelsen Sunnerdahls Handikappfond
ID : 40/19

Informations de copyright

© 2021. The Author(s).

Références

Birth Defects Orig Artic Ser. 1979;15(5B):113-29
pubmed: 393318
Oral Dis. 2017 Jan;23(1):42-49
pubmed: 27510842
Eur Endod J. 2018 Jul 19;3(2):118-122
pubmed: 32161867
Calcif Tissue Int. 2010 Jun;86(6):502-10
pubmed: 20411381
Am J Med Genet A. 2019 Dec;179(12):2393-2419
pubmed: 31633310
Am J Med Genet A. 2011 Jul;155A(7):1616-22
pubmed: 21626677
Calcif Tissue Int. 2017 Nov;101(5):473-478
pubmed: 28676897
J Craniofac Genet Dev Biol. 1987;7(2):127-35
pubmed: 3624418
J Clin Endocrinol Metab. 2000 May;85(5):1846-50
pubmed: 10843163
Eur J Hum Genet. 2015 Aug;23(8):1042-50
pubmed: 25944380
J Dent Res. 2008 May;87(5):414-34
pubmed: 18434571
J Pediatr Orthop. 2005 Nov-Dec;25(6):786-91
pubmed: 16294137
J Endod. 2016 Apr;42(4):669-72
pubmed: 26874642
J Dent Res. 1998 Jan;77(1):8-15
pubmed: 9437395
Bone. 2011 Jul;49(1):42-9
pubmed: 21281748
Arch Oral Biol. 2000 Mar;45(3):207-15
pubmed: 10761874
World Health Stat Q. 1988;41(1):32-6
pubmed: 3376487
Int Endod J. 2008 Dec;41(12):1123-36
pubmed: 19133103
Int J Dev Biol. 1995 Feb;39(1):35-50
pubmed: 7626420
J Dent Res. 2015 Jul;94(7):878-85
pubmed: 25910507
J Pediatr Orthop. 2007 Mar;27(2):225-7
pubmed: 17314651
Cochrane Database Syst Rev. 2008 Oct 08;(4):CD005088
pubmed: 18843680
Arch Dis Child. 2005 May;90(5):494-9
pubmed: 15851432
J Oral Rehabil. 2013 Aug;40(8):603-8
pubmed: 23691921
J Med Genet. 1979 Apr;16(2):101-16
pubmed: 458828
J Paediatr Child Health. 2018 Mar;54(3):223-233
pubmed: 29504223
PLoS One. 2017 May 12;12(5):e0176466
pubmed: 28498836
Acta Odontol Scand. 2002 Mar;60(2):65-71
pubmed: 12020117
J Clin Endocrinol Metab. 2003 Mar;88(3):986-92
pubmed: 12629073
Oral Surg Oral Med Oral Pathol. 1957 Nov;10(11):1204-18 contd
pubmed: 13477660
Cochrane Database Syst Rev. 2014 Jul 23;(7):CD005088
pubmed: 25054949
Scand J Dent Res. 1993 Oct;101(5):257-60
pubmed: 8248724
Acta Paediatr. 1998 Jan;87(1):64-8
pubmed: 9510450
Cell Tissue Res. 2007 Dec;330(3):475-85
pubmed: 17901984
J Dent. 2013 Aug;41(8):689-94
pubmed: 23778130
Acta Odontol Scand. 2001 Apr;59(2):111-2
pubmed: 11370748
Adv Dent Res. 1989 Sep;3(2):234-40
pubmed: 2640434
Orphanet J Rare Dis. 2020 Mar 31;15(1):80
pubmed: 32234057
Microsc Res Tech. 2012 Sep;75(9):1265-71
pubmed: 22508272
Int J Paediatr Dent. 2001 Mar;11(2):92-7
pubmed: 11310143
Nat Rev Dis Primers. 2017 Aug 18;3:17052
pubmed: 28820180
Calcif Tissue Int. 2020 Aug;107(2):143-150
pubmed: 32451573
J Endod. 2006 Jan;32(1):1-9
pubmed: 16410059

Auteurs

Barbro Malmgren (B)

Department of Dental Medicine, Division of Orthodontics and Pediatric Dentistry, Karolinska Institutet, POB 4046, 141 04, Huddinge, Sweden. barbro.malmgren@ki.se.

Irma Thesleff (I)

Developmental Biology Program, Institute of Biotechnology, University of Helsinki, Helsinki, Finland.

Göran Dahllöf (G)

Department of Dental Medicine, Division of Orthodontics and Pediatric Dentistry, Karolinska Institutet, POB 4046, 141 04, Huddinge, Sweden.
Center for Pediatric Oral Health Research, Stockholm, Sweden.
TkMidt - Center for Oral Health Services and Research, Mid-Norway, Trondheim, Norway.

Eva Åström (E)

Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
Pediatric Neurology, Astrid Lindgren Children's Hospital at Karolinska University Hospital, Stockholm, Sweden.

Georgios Tsilingaridis (G)

Department of Dental Medicine, Division of Orthodontics and Pediatric Dentistry, Karolinska Institutet, POB 4046, 141 04, Huddinge, Sweden.
Center for Pediatric Oral Health Research, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH